Table 2 Baseline patient characteristics and RBP4 serum concentrations
Parameter | All patients | Sepsis | Nonsepsis |
|---|---|---|---|
Number | 123 | 85 | 38 |
Sex (male/female) | 81/42 | 56/29 | 25/13 |
Age median (range) (yr) | 64 (18-81) | 64 (21-81) | 60 (18-79) |
APACHE-II score median (range) | 14 (0-31) | 14 (0-31) | 14 (0-31) |
SAPS2 score median (range) | 42 (0-80) | 42 (0-79) | 42 (13-80) |
ICU days median (range) | 8 (1-137) | 10 (1-137) | 5.5** (1-45) |
Hospital days median (range) | 26 (2-151) | 30 (3-151) | 14** (2-65) |
Death during ICU n (%) | 33 (27%) | 25 (29%) | 8 (21%) |
Death during follow-up n (%) | 59 (48%) | 41 (48%) | 18 (47%) |
30-day mortality (%) | 26.0 | 25.9 | 26.3 |
60-day mortality (%) | 34.4 | 35.7 | 31.6 |
90-day mortality (%) | 40.2 | 42.7 | 34.3 |
180-day mortality (%) | 43.5 | 46.9 | 35.3 |
1-year mortality (%) | 52.4 | 54.1 | 48.4 |
Mechanical ventilation n (%) | 78 (63%) | 53 (62%) | 25 (66%) |
Ventilation time median (range) (h) | 38 (0-2966) | 80 (0-2966) | 24** (0-755) |
pre-existing diabetes n (%) | 42 (34%) | 27 (32%) | 15 (40%) |
BMI median (range) (m2/kg) | 26.1 (15.3-59.5) | 26.2 (15.3-59.5) | 25.4 (19.0-53.3) |
RBP4 median (range) (mg/L) | 16.1 (0.3-147.6) | 15.2 (0.3-147.6) | 20.0 (1.0-118.6) |